Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
Studying both sexes: a guiding principle for biomedicine.
Are changes in gait and balance across the Disease Step Rating Scale in Multiple Sclerosis statistically significant and clinically meaningful?
EMD Serono Takes on Exclusive Promotion of Rebif® (interferon beta-1a) in the US
Information for healthcare professionals: Rituximab
Long term safety and efficacy study of teriflunomide 7 mg or 14 mg in patients with relapsing-remitting multiple sclerosis
Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.
Biogen Idec reports death of patient on its MS pill
US and EU regulatory authorities accept PLEGRIDY™ (peginterferon beta-1a) marketing applications for review
Gene Expression & Signaling in the Immune System
Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta-1a in subjects with normal or impaired renal function.
Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
Teva Pharmaceutical Industries Limited's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
The Charcot Lecture | Beating MS: A story of B cells, with twists and turns.
Gordon Research Conference on Ion Channels
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.

Pages